101 related articles for article (PubMed ID: 18001831)
21. pH-dependent disruption of erythrocyte membrane by amphiphilic poly(amino acid) nanoparticles.
Akagi T; Kim H; Akashi M
J Biomater Sci Polym Ed; 2010; 21(3):315-28. PubMed ID: 20178688
[TBL] [Abstract][Full Text] [Related]
22. Intracellular degradation and distribution of protein-encapsulated amphiphilic poly(amino acid) nanoparticles.
Akagi T; Shima F; Akashi M
Biomaterials; 2011 Jul; 32(21):4959-67. PubMed ID: 21482432
[TBL] [Abstract][Full Text] [Related]
23. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid).
Akagi T; Higashi M; Kaneko T; Kida T; Akashi M
Macromol Biosci; 2005 Jul; 5(7):598-602. PubMed ID: 15991216
[TBL] [Abstract][Full Text] [Related]
24. Fabrication and characterization of poly(gamma-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering.
Chang KY; Cheng LW; Ho GH; Huang YP; Lee YD
Acta Biomater; 2009 Jul; 5(6):1937-47. PubMed ID: 19282262
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells.
Yoshikawa T; Okada N; Oda A; Matsuo K; Matsuo K; Kayamuro H; Ishii Y; Yoshinaga T; Akagi T; Akashi M; Nakagawa S
Vaccine; 2008 Mar; 26(10):1303-13. PubMed ID: 18255205
[TBL] [Abstract][Full Text] [Related]
26. Transdermal immunization with low-pressure-gene-gun mediated chitosan-based DNA vaccines against Japanese encephalitis virus.
Huang HN; Li TL; Chan YL; Chen CL; Wu CJ
Biomaterials; 2009 Oct; 30(30):6017-25. PubMed ID: 19656560
[TBL] [Abstract][Full Text] [Related]
27. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.
Chen MC; Wong HS; Lin KJ; Chen HL; Wey SP; Sonaje K; Lin YH; Chu CY; Sung HW
Biomaterials; 2009 Dec; 30(34):6629-37. PubMed ID: 19767097
[TBL] [Abstract][Full Text] [Related]
28. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency.
Gao Y; Xu Z; Chen S; Gu W; Chen L; Li Y
Int J Pharm; 2008 Jul; 359(1-2):241-6. PubMed ID: 18479851
[TBL] [Abstract][Full Text] [Related]
29. Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles.
Swami A; Goyal R; Tripathi SK; Singh N; Katiyar N; Mishra AK; Gupta KC
Int J Pharm; 2009 Jun; 374(1-2):125-38. PubMed ID: 19446769
[TBL] [Abstract][Full Text] [Related]
30. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
[TBL] [Abstract][Full Text] [Related]
31. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814
[TBL] [Abstract][Full Text] [Related]
32. Preparation of size tunable amphiphilic poly(amino acid) nanoparticles.
Kim H; Akagi T; Akashi M
Macromol Biosci; 2009 Sep; 9(9):842-8. PubMed ID: 19422015
[TBL] [Abstract][Full Text] [Related]
33. Ternary complexes of pDNA, polyethylenimine, and gamma-polyglutamic acid for gene delivery systems.
Kurosaki T; Kitahara T; Fumoto S; Nishida K; Nakamura J; Niidome T; Kodama Y; Nakagawa H; To H; Sasaki H
Biomaterials; 2009 May; 30(14):2846-53. PubMed ID: 19232715
[TBL] [Abstract][Full Text] [Related]
34. Formation of unimer nanoparticles by controlling the self-association of hydrophobically modified poly(amino acid)s.
Akagi T; Piyapakorn P; Akashi M
Langmuir; 2012 Mar; 28(11):5249-56. PubMed ID: 22385355
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
[TBL] [Abstract][Full Text] [Related]
36. Preparation of chitosan nanoparticles using methacrylic acid.
de Moura MR; Aouada FA; Mattoso LH
J Colloid Interface Sci; 2008 May; 321(2):477-83. PubMed ID: 18295778
[TBL] [Abstract][Full Text] [Related]
37. Development of amphiphilic gamma-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier.
Yoshikawa T; Okada N; Oda A; Matsuo K; Matsuo K; Mukai Y; Yoshioka Y; Akagi T; Akashi M; Nakagawa S
Biochem Biophys Res Commun; 2008 Feb; 366(2):408-13. PubMed ID: 18068668
[TBL] [Abstract][Full Text] [Related]
38. Biodegradable interpolyelectrolyte complexes based on methoxy poly(ethylene glycol)-b-poly(alpha,L-glutamic acid) and chitosan.
Luo K; Yin J; Song Z; Cui L; Cao B; Chen X
Biomacromolecules; 2008 Oct; 9(10):2653-61. PubMed ID: 18754685
[TBL] [Abstract][Full Text] [Related]
39. Modulation of innate and adaptive immunity by biodegradable nanoparticles.
Uto T; Akagi T; Hamasaki T; Akashi M; Baba M
Immunol Lett; 2009 Jun; 125(1):46-52. PubMed ID: 19505507
[TBL] [Abstract][Full Text] [Related]
40. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
